Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 271 is a non-coding pseudogene in human genomic DNA, classified as a 5S ribosomal RNA pseudogene. Unlike functional 5S rRNA genes, which are integral structural components of the ribosome and play essential roles in protein synthesis and ribosomal assembly[1][3], RNA5SP271 does not produce a functional RNA or protein product. Pseudogenes like RNA5SP271 are typically regarded as evolutionary relics of functional genes, often harboring sequence similarity to their parent genes but lacking the ability to encode functional molecules[4][5]. Although some pseudogenes have been found to exert regulatory effects, such as competing for miRNA binding or generating regulatory small RNAs, there is no direct evidence that RNA5SP271 acts as a drug target or has a defined role as a biomarker. It is not a classical therapeutic target such as a receptor, enzyme, transporter, or transcription factor[5]. This target should not be considered a bona fide drug target or molecular receptor. If you are seeking a functionally active ribosomal target, consider specifying a protein-coding 5S ribosomal RNA gene rather than a pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 271 (RNA5SP271).